Aaron Ondrey
Director of Finance/CFO at ROCKET PHARMACEUTICALS, INC.
Net worth: 997 371 $ as of 2024-05-30
Aaron Ondrey active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-03-25 | - |
Career history of Aaron Ondrey
Former positions of Aaron Ondrey
| Companies | Position | Start | End |
|---|---|---|---|
| MIRATI THERAPEUTICS | Director of Finance/CFO | 2023-09-07 | 2024-01-22 |
| Corporate Officer/Principal | 2022-06-30 | 2023-09-07 | |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2010-02-28 | 2018-10-31 |
Training of Aaron Ondrey
| Case Western Reserve University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Aaron Ondrey
- Experience
